Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
NSAID-related gastrointestinal risks include: Dyspepsia and heartburn Gastric or duodenal ulceration Gastrointestinal bleeding or perforation Exacerbation of inflammatory bowel disease Certain patient groups face elevated risk when using NSAIDs, including older adults (over 65 years), those with previous peptic ulcer disease or gastrointestinal bleeding, patients taking corticosteroids, anticoagulants, selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), and those with Helicobacter pylori infection
As the sector evolves, stakeholders are urged to consider how these medications will reshape consumer habits, industry practices, and economic landscapes, emphasizing the need for strategic planning and proactive adaptation.
Each form has its own advantages and disadvantages, and the effectiveness and safety of each form can vary depending on several factors
Rarely, immune-related inflammation of the kidneys (acute interstitial nephritis) has been reported
